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SUMMARY
Centrioles are essential for the assembly of both centrosomes and cilia. Centriole biogenesis 
occurs once and only once per cell cycle and it is temporally coordinated with cell cycle 
progression, ensuring the formation of the right number of centrioles at the right time. The 
formation of new daughter centrioles is guided by a pre-existent, mother centriole. The proximity 
between mother and daughter centrioles was proposed to restrict new centriole formation until 
they separate beyond a critical distance. Paradoxically, mother and daughter centrioles overcome 
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that distance in early mitosis, at a time where triggers for centriole biogenesis Polo-like kinase 4 
(PLK4), and its substrate STIL, are abundant. Here we show that in mitosis, the mitotic kinase 
CDK1/CyclinB binds STIL, and prevents formation of the PLK4-STIL complex and STIL 
phosphorylation by PLK4, thus inhibiting untimely onset of centriole biogenesis. After CDK1/
CyclinB inactivation upon mitotic exit, PLK4 can bind and phosphorylate STIL in G1, allowing 
pro-centriole assembly in the subsequent S phase. Our work shows that complementary 
mechanisms, such as mother-daughter centriole proximity and CDK1/CyclinB interaction with 
centriolar components, ensure that centriole biogenesis occurs once and only once per cell cycle, 
raising parallels with the cell cycle regulation of DNA replication and centromere formation.
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INTRODUCTION
Centrosomes are the main microtubule organizing centers (MTOC) of mammalian cells [1], 
being composed of two centrioles. These are surrounded by the pericentriolar material, 
which nucleates microtubules and organizes the cytoskeleton. Centrioles can also nucleate 
the ciliary axoneme. Centriole number is highly controlled in cells; abnormalities can lead to 
defects in spindle and cilia assembly [1]. A new (daughter) centriole normally forms in 
physical proximity of a pre-existing (mother) centriole; this occurs once and only once per 
cell cycle (centriole-guided assembly). When no preexisting centrioles are found in a cell, 
centrioles can also form “de novo”, and in this case they form in random numbers [1]. 
Interestingly, the timing of centriole biogenesis is conserved in both; new centrioles only 
form in S-phase [2].
Both centriole-guided and de novo biogenesis are dependent on and initiated by Polo-like 
kinase 4 (PLK4) [3–5]. In the case of centriole-guided biogenesis, PLK4 is recruited to the 
proximal end of the mother centriole, determining the place of biogenesis [6]. PLK4 binds 
and phosphorylates STIL (SIL: SCL/TAL1/SAS-5/Ana2), recruiting it to the centriole [7–
11]. Phosphorylated STIL in turn brings SAS6 to the centrioles to form the centriole 
cartwheel [7, 8], the first visible structure in centriole assembly that helps defining the 
centriolar 9-fold symmetry [12]. Over-expression or stabilization of PLK4, STIL or SAS6 
leads to supernumerary centrioles, while their individual depletion blocks centriole 
duplication [3, 12].
Centriole biogenesis is tightly coupled to cell cycle progression. The formation of the 
cartwheel is detectable early in S-phase, concomitantly with the start of DNA replication [1, 
13]. Paradoxically, PLK4, STIL and SAS6 are present at the centrosome in mid-G1 up until 
the end of mitosis [9, 14–16]. The physical proximity between mother and daughter 
centriole is thought to prevent formation of yet another daughter centriole in S, G2 and 
Mitosis [1, 17]. However, already in a natural or arrested prophase and prometaphase, 
mother and daughter centriole reach a critical distance from each other shown to be 
permissive for centriole reduplication, yet they do not reduplicate at that stage [18–20]. 
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Moreover, it has been shown in both Drosophila and Xenopus egg extracts that while PLK4 
can induce de novo MTOC formation upon meiosis exit, it cannot do it in meiosis-arrested 
eggs or extracts [21, 22]. Together, these facts suggest the existence of additional levels of 
regulation during high CDK1/CyclinB activity phases, such as mitosis and meiosis.
Here, we explored the mechanism that couples cell cycle progression to the first molecular 
events in centriole biogenesis: PLK4-STIL complex formation and STIL phosphorylation. 
We show that CDK1/CyclinB prevents precocious PLK4-STIL complex assembly and STIL 
phosphorylation by PLK4, through direct binding to STIL. Upon mitotic exit and 
consequent CDK1/CyclinB degradation, PLK4 can bind and phosphorylate STIL, which 
recruits SAS6.
RESULTS
We first ask when the activity of the trigger of centriole biogenesis, PLK4, is required. We 
used Xenopus egg extracts which allow tight cell cycle synchrony and are naturally 
acentriolar, and therefore uniquely suited to investigate the biochemical regulation of de 
novo centriole biogenesis in the absence of physical constraints imposed by the close 
proximity of the mother centriole. Endogenous Xenopus PLK4 (PLX4) is not detectable in 
extracts and not sufficient to generate MTOCs de novo, presumably, due to low expression 
levels of this kinase [23]. However, overexpression of PLX4 is sufficient to induce de novo 
assembly of γ-tubulin-containing MTOCs [22], offering an assay to understand the 
biochemical connection between cell cycle and PLK4’s role in MTOC formation.
PLK4 can only trigger de novo MTOC formation after exit from M-phase
We used the well-characterized CSF-extract, which is prepared from Xenopus eggs arrested 
at the second meiotic metaphase (MII) by the cytostatic factor (CSF). This extract allows the 
sequential study of three different biochemical states. First, the CSF-arrested state (from 
here on referred to as “M-phase”), which has high CDK1/CyclinB activity (Figure 1A). 
Second, a CSF-exit/M-exit state, which normally onsets following fertilization, but can be 
artificially induced through the addition of Ca2+ to the M-phase extract [24]. The addition of 
Ca2+ inactivates the CSF, followed by cyclin degradation by the anaphase-promoting 
complex (APC/C), and dephosphorylation of CDK1/CyclinB substrates, such as Cdc25 
(Figure 1A). This biochemical state corresponds to a very low CDK activity state. Finally, 
we use an interphase (CSF-released) state, a later time point after Ca2+ addition to the CSF 
extract, which corresponds to S-phase, as embryonic cycles are devoid of defined gap 
phases, such as G1 [25] (Figure 1A).
Addition of recombinant Xenopus PLK4 (rPLX4WT) induces de novo assembly of MTOCs 
in cycling extracts positive for γ-tubulin ([22], and Figure S1A) and other centriolar markers 
(Cep135, Centrin-1, Figure S1B). Despite the similarity with centriole biogenesis, we never 
observed nine-fold symmetrical structures by electron microscopy (not shown), suggesting 
the lack of a limiting assembly factor.
To specifically inhibit PLK4’s activity along the cell cycle, we generated an ATP-analog-
sensitive recombinant PLX4 variant (also called “Shokat kinase” [26]), which can be 
Zitouni et al. Page 3
Curr Biol. Author manuscript; available in PMC 2017 May 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
specifically inhibited by ATP-analogues. Previously, the substitution of a Leucine residue by 
a Glycine (L89G) in the ATP binding pocket of hsPLK4 was reported to enhance the 
sensitivity to ATP analogues as desired ([27] and Figure S2A), albeit at the cost of a 10-fold 
reduction in activity in the absence of the ATP-analogue inhibitor ([27] and Figure S2B). 
After testing several combinations, we determined that a L89A substitution combined with a 
compensatory mutation outside of the ATP binding pocket (H188Y) ([28] and Figure S2A 
and S2B) restored both human and Xenopus PLK4’s activities to wild-type levels (Figure 
S2B and S2C). Hereafter, these Shokat alleles of PLK4 are referred to as recombinant 
analogue-sensitive PLX4/PLK4 (rPLX4AS/PLK4AS). rPLX4AS induced de novo formation 
of MTOCs as efficiently as rPLX4WT (Figure 1B and Movie S1). The ATP analogue 1-
Naphthyl-PP1 (1-NA-PP1) [29] was found to be a potent inhibitor of rPLX4AS but not of 
rPLX4WT (not shown) in vitro (Figure S2D and S2E and MovieS2).
Addition of rPLX4AS to either M-phase (Figure 1C, (i)), or M-exit extracts (Figure 1C, (ii)), 
allowed MTOCs to form after M-phase exit. Addition of rPLX4AS in interphase itself (when 
the extract had completely exited M-phase; “CSF-released”) did not trigger MTOC 
formation (Figure 1C, (iii)). To further investigate the timing we added rPLX4AS in M 
phase, and inhibited by 1-NA-PP1 in: M-phase (Figure 1D, (iv)), at the exit of M-phase 
(Figure 1D, (v)) or in interphase (Figure 1D, (vi)). We only observed MTOC formation if 
rPLX4AS was active at M-exit suggesting that it triggers de novo MTOC formation at a stage 
in which CDK activity is very low.
Centriole duplication in human cells requires active PLK4 after exit from mitosis
To investigate if a similar temporal requirement for PLK4 activity operates in the presence 
of centrioles and defined G1 and G2 phases, we generated a HeLa cell line conditionally 
expressing the human “Shokat” allele PLK4AS (L89A/H188Y) (Figure S2A–B and S2F). 
Cells were simultaneously depleted of endogenous PLK4, and induced to express RNAi-
resistant-PLK4AS, which rescued the reduction in centriole number caused by depletion of 
endogenous wild-type PLK4 (Figure S2G). Importantly, while 1-NA-PP1 treatment alone 
had no effect on centriole number or cell cycle progression (not shown), addition of 1-NA-
PP1 to the growth media ablated the ability of PLK4AS to rescue centriole duplication, while 
RNAi-resistant-PLK4WT (expressed from the same tetracycline-inducible promoter) was 
unaffected (Figure S2G).
1-NA-PP1 was added to synchronous cells expressing PLK4AS (and depleted of endogenous 
PLK4) at mitosis, G1, S-phase and G2 (monitored by flow-cytometry and EdU 
incorporation, Figure 2A and 2B, and enlarged in Figure S2H–I). The percentage of cells 
with the expected 4 centrioles in the subsequent mitosis was assessed. Similarly to Xenopus 
extracts, inhibition of PLK4 in a low CDK stage (mitotic exit and G1), reduced the 
percentage of cells able to duplicate their centrioles by approximately four-fold (Figure 2A 
and B). Surprisingly, given that centrioles start to be assembled in S phase, PLK4 inhibition 
during S-phase or G2 had no major effect on the number of centrioles present in mitotic cells 
in the same cycle (Figure 2A and 2B). We confirmed these findings using the recently-
described PLK4-specific inhibitor Centrinone [30]. Only cells inhibited from mitosis 
onwards, of the previous cycle, or from G1 of the same cycle, showed a significant decrease 
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in centriole duplication efficiency (Figure 2C and Figure S2J) suggesting, again, that PLK4 
acts in low CDK activity stages. In human cells, we could not perform controlled 
experiments of inhibition in mitosis, followed by release of inhibition as PLK4 catalyzes its 
own degradation [3]. Inhibited PLK4 accumulates, causing centriole over-amplification upon 
inhibitor wash-off (previously shown in [30]).
The PLK4-STIL complex only forms upon M-exit
To understand the regulation of PLK4 activity in time, we focused on the first reported event 
of centriole biogenesis: the formation of the PLK4-STIL complex and asked whether it 
occurs at M exit/G1. We first confirmed that STIL has a conserved role in MTOC formation 
in Xenopus extracts (Figure S3A–D). STIL is present and its depletion precluded the 
formation rPLX4-induced MTOCs (Figure S3A–C). Moreover, rPLX4AS was able to bind 
and phosphorylate STIL (Figure S3D). Our results suggest a general, conserved mechanism 
in which STIL is phosphorylated by PLK4 and is required for rPLX4-induced MTOC 
formation, similarly to what is described for human cells [7–10]. Next, we observed that 
rPLX4 cannot bind STIL in M-phase, but only after M-exit (Figure 3A), at which time it can 
also phosphorylate it (see shift of STIL band; Figure 3B).
We then asked how PLK4-STIL complex formation is regulated in the presence of centrioles 
in human cells. We immunoprecipitated FLAG-PLK4 from HeLa cells synchronized in 
different cell cycle stages preceding S-phase onset; mitosis (M), early (3hrs post mitosis – 
“PM”), mid (6hrs PM) and late (9hrs PM), G1 (Figure 3C–E and Figure S3E). Even though 
both STIL and PLK4 concentrations are highest in mitosis (Figure 3C–E and Figures S3F 
and S4A and S4B) [15, 16], PLK4-STIL interaction was only observed during mid and late 
G1 phases, 6 and 9hrs after mitotic exit respectively (Figure 3D and Figure S3E). PLK4 is 
detectable at the centrosome in those stages (Figure S4A and S4B), and consistently, the 
percentage of cells with STIL localizing to the centrosome increased significantly starting at 
mid-G1 (Figure 3E). This was followed by a significant increase of cells with SAS6 
localizing to the centrosome in late-G1 (9hrs PM; Figure S3G). Importantly, cells treated 
with the PLK4 inhibitor “Centrinone” for one hour prior to fixation, showed a marked 
reduction in STIL and SAS6 presence at the centrosome in G1 but not in mitosis (Figure 3E, 
S3G). Our observations suggest that either the recruitment or the maintenance of STIL, and 
consequently of SAS6, at the centrosome in human cells is dependent on PLK4 activity 
during G1.
Taken together, our results show that despite the fact that both STIL and PLK4 are present in 
high CDK1/CyclinB activity states in both acentriolar Xenopus egg extracts and in human 
cells, the two proteins do not form a complex in either of the systems at these stages (Figure 
3), suggesting a conserved inhibitory mechanism related to CDK1/CyclinB activity.
Inhibiting CDK1/CyclinB allows for PLK4-STIL complex assembly
We asked whether direct inhibition of CDK1 by the CDK1 inhibitor RO-3306 [31] would 
permit unscheduled complex formation. CDK1 inhibition in M-phase released the extracts to 
interphase, and this was sufficient for rPLX4 to bind -and likely phosphorylate-STIL (see 
STIL mobility shift upon rPLX4 addition; Figure 4A and 4B), and to induce MTOC 
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formation (Figure 4C). Likewise, acute inhibition of CDK1 activity in human cells blocked 
in mitosis restored the PLK4-STIL interaction (Figure 4D and Figure S4C). Taken together 
these results strongly corroborate an inhibitory function of CDK1 in PLK4-STIL complex 
assembly.
CDK1/CyclinB phosphorylates and binds to STIL
CDK1/CyclinB prevents the initiation of DNA replication (i.e. licensing) both by 
phosphorylation of (i.e. Orc2) and binding to (i.e. Orc6) components that are required for 
that step [32, 33]. We thus asked whether CDK1/CyclinB could regulate PLK4-STIL 
complex assembly, either by phosphorylating and/or binding to STIL.
Given that STIL is highly phosphorylated in M-phase (Figure S5A) and its localization at 
the centrosome is dependent on CDK1 activity [34], we tested whether it is a substrate of 
CDK1/CyclinB. In vitro kinase assays show incorporation of 32P-radiolabeled-ATP into 
STIL in the presence of either CDK1/CyclinB or PLX4 (positive control) (Figure S5A and 
S5B).
We then ask whether CDK1/CyclinB could phosphorylate and/or bind the domains/residues 
in STIL that normally bind/are phosphorylated by PLK4, to prevent their interaction. PLK4 
binds to STIL in the coiled-coil domain ([7–10] and Figure 5A; “CC”) and phosphorylates 
STIL on a domain known as STAN motif; leading to SAS6 recruitment and cartwheel 
assembly [7–10]. We used HA-tagged Full Length STIL (FL) and truncated STIL fragments 
previously described by Ohta and colleagues [7] (ΔCC, N-terminal domain (N) and N3C, 
Figure 5A) expressed in HEK293T cells, as substrates in an in vitro kinase assay. 
Importantly, we show that CDK1/CyclinB phosphorylates the N-terminal domain of STIL, 
but not the region encompassing the CC or STAN motifs (Figure 5B–C and confirmed with 
phospho-specific antibodies against a residue phosphorylated by PLK4 S1116 in the STAN 
domain [8] in Figure 5D). Therefore, CDK1/CyclinB phosphorylates STIL but on a 
physically distinct site to the one bound and phosphorylated by PLK4.
We then tested whether CDK1/CyclinB could bind STIL in vivo. We observed that indeed 
CDK1/CyclinB co-immunoprecipitates with STIL in Xenopus extracts arrested in M-phase, 
but not after M-exit when Cyclin B is degraded (Figure 6A and B). Similarly, when treating 
M-phase extracts with the CDK1 inhibitor RO-3306 in which the CDK1/CyclinB complex is 
inactive, but CyclinB is not degraded due to the natural absence of Cdh1, inactivated CDK1/
CyclinB could not bind STIL (Figure S5C1). Conversely, PLK4 binding to STIL was re-
established (Figure S5C2).
We then asked whether binding of CDK1/CyclinB to STIL would prevent STIL from 
interacting with PLK4. We performed CDK1/CyclinB immunoprecipitation from HEK293T 
cells expressing HA-tagged-FL-STIL, or the truncated fragments: ΔCC, which does not bind 
PLK4 [7–10], and an N-terminal domain (N). We found that while CDK1/CyclinB binds 
FL-STIL and N-STIL, it does not bind ΔCC-STIL (Figure 6A, C). Despite this, ΔCC-STIL 
is phosphorylated by CDK1/CyclinB (Figure 5B); suggesting that in vitro phosphorylation 
and binding are not mutually dependent. More importantly, our results show that binding of 
CDK1/CyclinB to STIL requires the CC-domain of STIL.
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We then asked whether the CC-domain is sufficient for CDK1/CyclinB binding. 
Immunoprecipitated CDK1 from HEK293T cell expressing GFP-CC [10] or GFP-FL STIL 
is able to efficiently bind both GFP-CC and GFP-FL (but not GFP alone) (Figure 6D). Our 
results demonstrate that the CC-domain is both necessary and sufficient for CDK1/CyclinB 
binding to STIL.
CDK1/CyclinB binds STIL preventing STIL-PLK4 complex formation and STIL 
phosphorylation by PLK4
Our results raise the intriguing possibility that CDK1/CyclinB and PLK4 may compete for 
binding to STIL. We tested this hypothesis using a GST-N3C-ΔSTAN-STIL fragment. 
Remarkably, we observed that although both proteins can interact separately with GST-N3C-
ΔSTAN (Figure 6E, I and II, and Figure S6A), initial incubation of this fragment with 
CDK1/CyclinB, prevents PLX4 from binding to it (Figure 6E, III, and Figure S6A). 
Moreover, this assay was performed in the absence of ATP, reinforcing that binding and 
phosphorylation of STIL by CDK1/CyclinB might not be linked. Importantly, we observed 
that increasing concentrations of CDK1/CyclinB are able to physically displace a constant 
amount of PLK4 from binding STIL immunoprecipitated from Xenopus interphase extracts 
(Figure S6B).
Finally, we asked whether CDK1/CyclinB–STIL binding would also preclude STIL 
phosphorylation by PLK4 in the STAN motif, which is the critical event that recruits SAS6 
[7, 8, 11]. We used FL-STIL and incubated it with PLK4 and CDK1/CyclinB individually or 
sequentially, and asked whether PLK4 can phosphorylate STIL in S1116 (Figure 6F). If 
PLK4 accesses STIL alone, or first, it is able to phosphorylate S1116 (Figure 6F, III). 
However, pre-incubation of CDK1/CyclinB precludes PLK4 phosphorylation (Figure 6F, 
IV). Previous reports indicated that PLK4 interaction with STIL, enhances PLK4’s activity 
[8]. Consistently, we observed that PLK4 auto-phosphorylation is reduced when its binding 
to STIL is disrupted by the presence of CDK1/CyclinB (see PPLK4 levels in Figure S6C, III 
vs. IV). In summary, we showed that CDK1/CyclinB prevents the STIL-PLK4 interaction by 
binding STIL in a kinase-independent fashion through the same region as PLK4. In turn, this 
prevents both the phosphorylation of STIL by PLK4, and further activation of PLK4. Given 
the low concentration of PLK4 in the cell [23], it is likely that CDK1/CyclinB is able to 
prevent PLK4’s binding to STIL in mitosis.
DISCUSSION
A critical ill-understood question in centriole biogenesis is how the cell division and 
centriole duplication cycles are coupled, so that centriole assembly occurs once and only 
once per cell cycle. Here we show how the first known biochemical event in centriole 
biogenesis, the association between PLK4 and its substrate STIL, is regulated during the cell 
cycle. We demonstrate that PLK4 activity is needed for centriole biogenesis before pro-
centrioles become detectable in S-phase. PLK4 binds and phosphorylates STIL in mid-G1. 
We show that the major mitotic kinase, CDK1/CyclinB, prevents precocious PLK4-STIL 
complex assembly and STIL phosphorylation in mitosis, by binding to STIL in the same CC 
domain. These observations strongly support a model in which (see graphical abstract): i) in 
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S phase and early G2 centriole reduplication is inhibited by centriole physical proximity, ii) 
in early mitosis centrioles are separated a critical distance for reduplication [18–20], and 
PLK4 and STIL levels are very high [15, 16]. However, CDK1/CyclinB prevents STIL from 
interacting with and being phosphorylated by PLK4, releasing it from the centriole [34], iii) 
after mitotic exit, following inactivation of CDK1, and new synthesis of STIL and PLK4 in 
mid-G1, PLK4 can bind and phosphorylate STIL [7–10, 35], iv) phosphorylated STIL 
recruits SAS6 [8, 9, 11] and new cartwheel formation starts at the G1/S boundary [12]. Our 
work provides a mechanistic link between cell cycle progression and centrosome biogenesis 
and a rationale for the observation that centriole biogenesis can only start after exit from 
mitosis.
Our model is supported by previous unexplained findings; inhibition of CDK1/CyclinB in 
Drosophila wing disc cells, Chinese Hamster Ovary cells (CHO) and chicken DT40 cells 
leads to unscheduled centriole formation [36, 37]. Moreover, previous work from our 
laboratory demonstrated that PLK4 overexpression can only drive de novo centriole 
biogenesis upon exit from meiosis in Drosophila eggs, suggesting that inhibition by CDK1/
CyclinB in M phase could limit PLK4 activity in many contexts [21]. We note, however, that 
our model does not exclude additional roles of CDK1 in centriole biogenesis regulation 
through the activation or inhibition of additional regulators and/or substrates.
Remarkably, the results we present here can be paralleled with licensing mechanisms shown 
originally to operate in DNA replication and more recently, for centromere assembly (for a 
review on this topic, see ref. [38]) in certain aspects. In both cases, critical “licensing” events 
can only occur in G1. This is the loading of the helicase that unwinds the DNA onto the 
origins of replication, or the loading of the centromeric histone H3, CENP-A, to 
centromeres. CDK1 inactivates the licensing factor Cdt1, and binds to Orc6 [32, 33, 39], and 
also prevents loading of CENP-A in different ways [40]. Therefore, both in the case of DNA 
replication and centromere assembly, CDK1 prevents untimely interactions, ensuring those 
events occur only once per cell cycle. Assembly of the PLK4-STIL complex in G1, 
separated from centriole assembly in S-phase, can be thought as a sort of “licensing” event 
for centriole duplication, ensuring it occurs “once and only once” per cell cycle. Additional 
layers of regulation, such as centriole proximity [17, 18], clearly operate in addition to the 
mechanism we uncovered here to prevent unscheduled licensing in S and G2 phases.
Our results raise several important questions for understanding how centriole numbers are 
controlled. Whereas binding of CDK1/CyclinB to STIL requires an active CDK1/CyclinB 
complex, it is not phosphorylation dependent (Figure 6E), giving rise to the intriguing 
possibility that phosphorylation and binding could regulate independent aspects of STIL’s 
biology in the cell. Where is CDK1 binding STIL- is it to the cytoplasmic or the centrosome 
pool? Furthermore, how are degradation of STIL by the APC/C in mitotic exit [15, 34], and 
translation dynamics of new protein pools in G1 fine-tuned? Understanding those will 
explain why critical events start in mid-G1 and not immediately after CyclinB degradation. 
Finally, what role do CDK2/Cyclin complexes [41–45] play in regulating PLK4-STIL 
complex formation? Quantitative knowledge of the different pools of players, of their 
affinity to each other and of the regulatory mechanisms, will lead to a more cohesive 
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understanding of the overarching principles governing the cell-cycle coordination of 
synchronously-occurring cellular processes.
MATERIALS AND METHODS
Plasmid, cloning, protein expression and cell culture
The PLX4 and PLX4AS cDNAs were cloned into pFastBac HTb plasmid and expressed in 
SF21. HeLa cell lines were generated by electroporation of siRNA resistant cDNA of 
3xFLAG-SBP-hPLK4AS/WT. HA-tagged FL-hSTIL, ΔCC, N-terminal (N) [7], and GFP-CC 
[10] were expressed in HEK293T. GST-N3C (ΔSTAN) was generated in a previous study 
[7]. Protein expression was performed as described previously [7].
Protein Detection
Cell lysis was performed in lysis buffer, 50–75 μg of protein were run on a 4–15% TGX gel 
(Bio-Rad), transferred onto a nitrocellulose membrane, and blotted following standard 
protocols. Antibodies used for protein detection and immunofluorescence assays are 
specified in Supplementary Experimental Procedures. Polyclonal anti-PLX4 was generated 
in this study.
Preparation of Xenopus Egg Extracts and MTOC formation assay
CSF arrested and interphase egg extracts were prepared as previously described [46]. 
Purified PLX4AS was added to 20 μl of CSF extracts at 0.675 μM and released into 
interphase by calcium addition (20 mM CaCl2). MTOCs were analyzed by using TRITC-
Rhodamine labeled porcine tubulin (Cytoskeleton catalogue #TL590M, lots #017).
Synchronization, Depletion, Induction and Inhibition Experiments in HeLa Cells
Depletion of endogenous PLK4 was performed using siRNA oligos (see table in Supp. Exp. 
Proc.). Expression of PLK4AS/WT was induced with tetracycline. 1-NA-PP1 was used to 
inhibit PLK4AS. 2 nM (17 hrs) thymidine (supplemented with 10 μM EdU or BrdU) was 
used for S-phase block, 100 ng/mL (12 hrs) nocodazole or 2.5 μM monastrol (14 hrs) were 
used for mitotic block. G1 time-points were obtained by mitotic shake-off.
Immunoprecipitation and Kinase Assays
Immunoprecipitated STIL was washed with RIPA, and co-precipitated proteins were 
separated on a 4–15% TGX SDS-PAGE gel (Bio-Rad). Kinase reaction was performed in 
kinase buffer supplemented with ATPγS and myelin basic protein (MBP). Radioactive 
kinase reactions were performed in the presence of 1 μCi [γ-32P] ATP (replenishing ATP 
between kinases in the case of sequential incubations). For phosphorylation assays, GST-
hSTIL (FL) [8] or immunoprecipitated STIL were incubated in kinase buffer supplemented 
with 500 ng CDK1/CyclinB and/or 500 ng of PLK4. For sequential incubation; GST-N3C 
(ΔSTAN) was incubated in binding buffer containing 500 ng of CDK1/Cyclin, washed, 
subsequently incubated with 500 ng of GFP-PLX4, and eluted in Laemmli buffer. Assays 
were analyzed by Coomassie staining, autoradiography or western blotting.
Zitouni et al. Page 9
Curr Biol. Author manuscript; available in PMC 2017 May 09.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
For immunoprecipitation from human cells 1–2 mg of total whole-cell lysate was incubated 
with protein-G coupled to the appropriate antibody, washed, and eluted in Laemmli buffer.
Immunofluorescence assays, Microscopy and Flow cytometry analysis
Staining with 5-Ethynyl-2′-deoxyuridine was performed using the Click-iT EdU Alexa Fluor 
647 Imaging Kit (Thermo Fisher Scientific). Propidium iodide, or bromodeoxy-Uridine 
staining were analyzed on a BD FACScan flow cytometer. Data were plotted and analyzed 
using FlowJo (Tree Star Inc.). Images were collected on a DeltaVision microscope (Applied 
Precision) using softWoRx (Applied Precision software) or a Spinning Disk CSU-X1 
(Yokogawa) confocal scan head coupled to a Nikon Eclipse Ti-E and controlled using 
MetaMorph 7.5 (Molecular Devices). GraphPad Prism (version 5.0c, La Jolla, California, 
USA) was used for statistical analyses and plotting.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. PLX4 induces de novo aster formation early after M-phase (CSF) release in Xenopus 
egg extracts
A. Cell cycle profiling of Xenopus M-phase extracts released with Ca2+. Western blots 
(WB) show the kinetics of Cdc25 downshift and CyclinB2 degradation leading to reduced 
CDK1 activity. B. GFP-PLX4AS-induces MTOC formation in M-phase released 
extracts. CSF extract was incubated with 0.65 μM GFP-PLX4AS, (green) and TRITC-
tubulin (red). See also Figure S1, S2C for the generation and characterization of Shokat 
alleles. (See also Movie S1 and S2) C. Cell cycle-dependent effect of PLX4. rPLX4 was 
added at different time points: (i) 10 mins before release (add Ca2+), (ii) concomitantly with 
release, and (iii) 20 mins after release, in order to check when PLK4 activity is needed to 
form MTOCs (TRITC-tubulin). D. Inhibition of PLX4AS using 1 NA-PP1 at different 
stages. PLX4AS was added 10 mins before Ca2+ and was inhibited by 1NA-PP1 in extracts 
at different time points: (iv) at time zero (v) with Ca2+, and (vi) 20 mins after Ca2+. Panels 
of MTOCs formed in the extract under each condition, stained with TRITC-tubulin, are 
shown. Asters were counted in 10 images for each condition, and normalized to the number 
of asters observed in control extracts ((i) in C and PLX4AS in D) (n=3, Bars represent 
average +/
−
SD).
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Figure 2. PLK4 activity is needed at M-phase exit/G1 for centriole duplication in human cells
A–C. PLK4 activity was inhibited at different cell cycle times by 1NA-PP1 (PLK4AS) 
(B) or centrinone (C), and centrioles were counted in the subsequent mitosis. A. 
Experimental scheme and summary of results from B–C. B. 1NA-PP1 was added to cells 
expressing PLK4AS and depleted of endogenous PLK4 at 0 hrs (positive control, (+)), 6 
(G2), 8 (M), 10 (M-exit/G1) and 20 hrs (S-phase) following S-phase block release. Cells 
were fixed in the immediate subsequent mitosis, and centrioles counted (n=3, 100 cells/
condition, mean +/− SEM. ** = p<0.01). Cell cycle profiles were obtained by flow 
cytometry. Percentage of S-phase cells at time of inhibition were monitored by EdU staining 
(See also Figure S2F–I for controls). C. Centrinone was added at the indicated cell cycle 
stages and centrioles were counted in the subsequent mitosis. (n=3, 100 cells/condition. 
mean +/− SEM. ** = p<0.01). Representative immunofluorescence images of mitotic cells 
stained as indicated, following inhibition of PLK4 by centrinone. The number of centrioles 
found with the highest frequency upon inhibition is shown (average of 3 experiments). See 
Figure S2J for detailed quantitation.
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Figure 3. The PLK4-STIL complex forms only upon M-exit in Xenopus extracts and human cells
A. PLX4 binds STIL only after mitotic-exit in Xenopus extracts. (See also Figure S3A–
D). rPLX4 was supplemented to extracts at the indicated stages, and subsequently 
immunoprecipitated (PLX4-IP). Samples were analyzed by WB, and probed with the 
indicated antibodies. (*) refers to an interphase extract (see methods). B. PLX4 is likely to 
phosphorylate STIL upon M-exit in Xenopus extracts. Released-extracts were 
supplemented with rPLX4. STIL phosphorylation (note the mobility shift) and levels of 
CyclinB2 were analyzed by WB. C. STIL peaks in mitosis in human cells. FLAG-PLK4 
over-expressing HeLa cells were synchronized in mitosis by monastrol, and released. 
Samples were collected at the indicated times. D. The PLK4-STIL complex forms in mid-
G1. FLAG-PLK4 was immuno-precipitated from cell lysates at the indicated stages. 
Samples were probed with the indicated antibodies. Cell cycle profiles were obtained by 
flow cytometry combined with BrdU-FITC labeling of cells in S phase. See Figure S3E for 
more details. E. STIL recruitment to the centrosome during mid-G1 phase is dependent 
on PLK4 activity. Presence of STIL at the centrosome was quantified by 
immunofluorescence using anti-STIL in mitotic or G1 cells obtained after mitotic shake-off. 
DMSO (control) or centrinone (PLK4 inhibitor) was added 1hr prior to fixation. The 
absence of S-phase cells in G1 was corroborated by EdU incorporation. (n=3, 100 cells/
condition, mean +/− SEM). See also Figure S3F, S3G, S4A and S4B for more details on 
these experiments.
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Figure 4. PLK4-STIL complex formation is inhibited by CDK1. A. Inhibiting CDK1 allows 
PLK4-STIL complex assembly
STIL was immunoprecipitated from extracts treated as indicated. Samples were analyzed by 
WB, probed with the indicated antibodies. Fold increase over control in signal intensity was 
quantified for each condition. Note that endogenous PLX4 is undetectable. *Addition of 
RO-3306, a CDK1 inhibitor, releases the extract into interphase. B. Phosphorylation of 
STIL in CSF/M-phase arrested extracts treated with RO-3306. M-phase extracts were 
treated as indicated. STIL phosphorylation and CyclinB2 were analyzed by WB. C. PLX4 
induces asters in M-phase extracts released with RO-3306. Confocal images of M-phase 
extracts supplemented with rPLX4 and 100 μM RO-3306, in the presence of TRITC-labeled 
tubulin. D. CDK1/CyclinB activity is inhibitory for the formation of the PLK4-STIL 
complex. Nocodazole arrested cells in mitosis were treated as indicated. STIL was 
immunoprecipitated and samples were probed with the indicated antibodies. Note that under 
centrinone treatment, PLK4 accumulates [30]. Cell cycle profiles were obtained by flow 
cytometry; see Figure S4C for details.
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Figure 5. CDK1/CyclinB phosphorylates STIL outside of the PLK4 interacting domain in human 
cells
A. Schematic representation of HA- and GST-tagged STIL constructs. The evolutionary 
conserved coiled-coil (CC; PLK4-binding) and STAN (PLK4-phosphorylated and SAS6 
binding) domains are indicated. Constructs were used for phosphorylation assays. The 
results are summarized on the right. B. CDK1/ Cyclin B can phosphorylate STIL on its N-
terminus. Autoradiography of an In vitro kinase assay using IP control, or HA-STIL (FL, 
ΔCC, N and N3C), CDK1/Cyclin B and ([γ-32P]-ATP). Black arrows show phosphorylated 
fragments. White arrow indicates the expected position of the non-phosphorylated N3C 
fragment (n.s.=non-specific). Note that all fragments, but not the N3C, are phosphorylated 
by CDK1/CyclinB. C. STIL-N3C, the domain that interacts with PLK4 and SAS6, is not 
phosphorylated by CDK1/CyclinB. Incorporation of [γ-32P] on STIL-N3C incubated with 
GFP-PLX4 or CDK1/CyclinB was visualized by autoradiography. D. CDK1/CyclinB does 
not phosphorylate STIL on the site phosphorylated by PLK4 (S1116). Recombinant 
GST-STIL (FL) was incubated with rPLX4 or CDK1/CyclinB. Samples were analyzed by 
WB using anti-pS1116-STIL (which recognizes a PLK4-specific phosphorylation [8]), anti-
His and anti-CDK1 to monitor loaded proteins.
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Figure 6. CDK1/Cyclin B binds STIL on its CC domain and competes with PLK4 binding
A. Representation of HA-, GST- and GFP-tagged STIL constructs and summary of 
results. The evolutionary conserved coiled-coil (CC; PLK4 binding) and STAN (PLK4 
phosphorylated and SAS6 binding) domains are indicated. B. CDK1/CyclinB and PLK4 
bind STIL at different stages. rGST-STIL and rPLX4 were added to CSF extracts which 
were kept arrested or released to interphase with Ca2+. GST-STIL was immunoprecipitated 
and samples were analyzed by WB. See Figure S5D and S5E. C. The STIL-CC motif is 
necessary for CDK1/CyclinB binding. HEK293T cells were transfected with the indicated 
plasmids and CDK1 was immunoprecipitated. Samples were visualized by WB using the 
indicated antibodies. D. The STIL-CC motif is sufficient for CDK1/CyclinB binding. 
CDK1 was immunoprecipitated from HEK293T cells expressing GFP, GFP-CC or GFP-FL-
STIL. Co-immunoprecipitates were probed with the indicated antibodies (n.s.= non-specific; 
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cross reaction of the mouse anti-GFP antibody with rabbit IgGs used to IP CDK1). E. 
CDK1 binding to STIL prevents subsequent PLX4 binding. GST-N3CΔSTAN was 
incubated as indicated in the scheme, pulled-down, and its co-precipitated proteins were 
analyzed by WB. See Figure S6A and S6B for quantification (n=3) and titration 
experiments. F. CDK1 binding of STIL prevents its phosphorylation by PLX4. GST-
STIL (FL) was incubated as shown in the scheme. STIL phosphorylation by PLX4 in the 
STAN motif was analyzed by WB using the indicated antibodies. See Figure S6C for more 
details on this experiment.
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